The Dental and Pharmaceutical Benefits Agency, TLV, is a central government agency whose remit is to determine whether a pharmaceutical product or dental care procedure shall be subsidized by the state.

Our duty is to examine which medicines, medical devices and dental care treatments will be subsidised by society. We also contribute to quality service and accessibility of pharmacies.

Our duty is to examine which medicines, medical devices and dental care treatments will be subsidised by society.In addition to examining new medicines, we also work systematically to evaluate the medicines included in the high-cost threshold to determine whether their reimbursement should be maintained or restricted.

On the pharmacy market our remit is to create the conditions for quality service and accessibility at pharmacies. We do this partly through the generic substitution system, the retail margin for pharmacies and by monitoring the pharmacy market.

Furthermore, we decide how much a medicine or a medical device in the high-cost threshold should cost. And, we determine what margin pharmacies should use when selling products, meaning the difference between the wholesale and retail prices.

We determine the pricing for new dosage forms, strengths and packaging and examine whether they should be included in the high-cost threshold.

Dental

Pharmaceutical

The Dental and Pharmaceutical Benefits Agency, TLV

Sofia Wallström

Per Andersson

Marie Orre

Carl Björvang

Lars Jaatinen

Mikael Moutakis

Martin Karlsson

Jonas Samuelsson

Douglas Lundin

Hanna Zirath

The Analysis and Research Team at The Dental and Pharmaceutical Benefits Agency, TLV, is responsible for conducting comprehensive evaluations and data-driven research to inform the subsidization decisions for medicines, medical devices, and dental care treatments. This team analyzes the cost-effectiveness and societal impact of new and existing pharmaceutical products and dental procedures, ensuring that they meet the criteria for inclusion in the high-cost threshold. Additionally, the team contributes to policy formulation related to pricing, generic substitution, and the retail margin for pharmacies, ensuring accessibility and quality service within the pharmacy market.

Analysis and Research Team

Analysis and Research Team

About

Team members